- Home
- ZTO vs BDTX Comparison
ZTO vs BDTX Comparison
Compare ZTO & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZTO | BDTX |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 220.3M |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ZTO | BDTX |
|---|---|---|
| Price | $20.97 | $2.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $21.90 | $10.60 |
| AVG Volume (30 Days) | 1.6M | ★ 1.7M |
| Earning Date | 11-19-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.16 | 0.38 |
| Revenue | ★ $6,673,175,085.00 | $70,000,000.00 |
| Revenue This Year | $12.15 | N/A |
| Revenue Next Year | $11.36 | N/A |
| P/E Ratio | $18.48 | ★ $7.38 |
| Revenue Growth | ★ 13.17 | N/A |
| 52 Week Low | $16.34 | $1.20 |
| 52 Week High | $22.01 | $4.94 |
Technical Indicators
Market Signals| Indicator | ZTO | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.42 | 30.62 |
| Support Level | $20.71 | $2.61 |
| Resistance Level | $21.68 | $2.84 |
| Average True Range (ATR) | 0.37 | 0.26 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 56.90 | 26.81 |
Price Performance
Historical ComparisonAbout ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 19.4% in 2024. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 78% voting rights as of March 31, 2025. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 8.9% interest.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.